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Abstract: The design process for medical devices is highly regulated to ensure the safety of patients. This paper will 
present a review of the design process for implantable orthopedic medical devices. It will cover the main stages of 
feasibility, design reviews, design, design verification, manufacture, design validation, design transfer and design 
changes. 
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1. INTRODUCTION 
  The design process for medical devices is highly 
regulated to ensure the safety of patients and healthcare 
workers. The Medical Device Directive [1] was developed to 
regulate medical devices in Europe. It is a document that is 
legally binding, enforceable in law and with penalties for 
non-compliance. Regulations outside Europe vary. For 
example, in the United States of America, the Food and Drug 
Administration (FDA) is responsible for the safety of 
medical devices [2]. In order to comply with the regulations, 
companies are required to have a quality management 
system in place [3-5] to ensure that the whole design process 
is managed and planned in a systematic and repeatable 
manner. To show compliance with the regulatory aspects it is 
necessary to maintain a Design History File (which can also 
be know as a Technical File or Design Dossier) which 
describes the design history of a product and is maintained 
post-product release to include subsequent changes to the 
product and relevant post-market surveillance data. The aim 
of this paper is to give an overview of the design process for 
implantable orthopedic medical devices. 
2. DESIGN PROCESS 
2.1. Overview 
  The medical device design process, as with other design 
processes, can be broadly divided into six areas [6-9]: 
1. Market 
2. Design  specification 
3. Concept  design 
4. Detail  design 
5. Manufacture 
6. Sell 
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  However, in this paper we propose a more detailed 
structure to the design process, shown in Fig. (1). Each of 
these aspects of the design process will be discussed in the 
following sections. 
2.2. Feasibility 
2.2.1. Design Inputs 
  Ideas for new or improved medical devices will come 
from surgeons, other clinicians, sales teams or medical 
engineers, perhaps working together as an interdisciplinary 
team. At the initiation of the project the basic objectives and 
clinical indications for the device will be defined. A surgical 
review panel may be formed to help guide the design and 
ensure that the device functions correctly surgically and that 
any instruments are suitable for use by the surgeon. 
2.2.2. Commercial Aspects 
  There has to be a market or customer need for a medical 
device to be designed and produced. It is not commercially 
viable to design a device that has a limited market, whether 
this is due to competition from well established products or 
from a limited numbers of patients. A feasibility study for a 
new idea for a device needs to be undertaken to identify the 
potential market share, similar devices produced by 
competitor companies and the potential market value of 
devices. A review of the intellectual property is also required 
to determine whether the design can be protected and does 
not infringe other patents. 
2.2.3. Planning 
  It is important that each aspect of the design process is 
project managed with achievable milestones set and defined 
throughout the project life cycle. The setting of milestones 
should enable the project manager to assess the progress of 
the project to ensure that it is completed on time and within 
budget. The definition of the milestones should detail the 
requirements for the project to pass the milestone, for 
example completing the market feasibility report and the 
project objectives. The project plan should include regular 
milestones and project meetings to assist with the 22    The Open Biomedical Engineering Journal, 2009, Volume 3  Aitchison et al. 
identification of problems and allow early action to be taken 
to counteract delays to a project. The planning process 
should also include a risk management plan, which should 
highlight the relevant strategies that will be employed to 
reduce and manage the risks that are associated with a 
project. Finally the planning process should identify the 
human and financial resources required to be in place to 
successfully realise a design. 
2.2.4. Regulatory Requirements 
  All medical devices must have regulatory approval 
before they can be released to market. There are a number of 
internationally and nationally agreed requirements to which 
medical devices must conform. Currently these standards are 
not harmonized, and there are differences between those that 
regulate Europe and the United States. Medical devices must 
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also be classified according to the level of risk associated 
with their use upon a patient and to the user. The 
classification process of a medical device will determine the 
relevant approval route to market. It is therefore essential 
that the regulations that will influence the design of a 
product are identified early in the design process. 
Independent advice on this area must be sought from a 
Regulatory Authority, Conformity Assessment Body or other 
authorised third party. 
  In the design of the product it is necessary to identify 
global standards, which apply to all medical devices, semi-
global standards which apply to a particular family of 
devices and specific standards that apply to particular 
devices or pieces of equipment. By identifying these 
standards complications in the latter stages of the design 
process can be avoided. Whilst not all of the standards are 
mandatory, compliance will often help to accelerate the 
approval process. 
2.2.5. Design Requirements 
 The design requirements (or product design 
specification) are essential before a medical device can be 
designed. It sets out exactly what is required of the design 
against which each stage of the design can be verified. 
Whilst the initiation of the project will highlight some of the 
technical requirements for a project, it is important to 
perform a thorough requirement capture process to ensure 
that all of the functional performance needs are identified 
early in the design process. It is important to remember that 
the requirements are solution independent to prevent 
narrowing the design options available. A general standard 
exists to help determine the design requirements [10]. Many 
types of medical device also have particular requirements, 
such as joint replacement implants [11] and implants for 
osteosynthesis [12]. In addition, specific requirements can be 
specified for certain devices, such as joint replacement 
implants for the hip and knee [13,14]. 
  Most implants require custom designed surgical 
instruments and it is vital to consider the product design 
specification for the instruments at an early stage as they 
interact with the implant [15]. Any design changes to the 
implant will have a knock-on effect for the design of the 
instrument. In many cases the complexity and design time of 
the surgical instruments are greater than the actual implant 
itself. The standard BS EN 12011 [16] has been produced to 
help identify the requirements for surgical instruments. It is 
also important to consider the packaging, sterilization [17] 
and labeling [18] at an early stage, as these are an integral 
part of the whole device. The design requirements for the 
device will include: 
•  intended performance 
•  design attributes 
•  materials 
•  design evaluation 
•  manufacture 
•  testing 
•  instruments required 
•  sterilization 
•  packaging 
•  information to be supplied by the manufacturer 
  The design requirements vary between orthopedic 
devices. For a total knee arthroplasty the important 
requirements would be for the implant to last for 25 years, 
have the required range of motion, prevent loosening and 
minimise wear debris [19]. In the design of a new wrist 
arthroplasty it would be important to consider the range of 
motion (flexion/extension, radial/ulnar deviation or radio-
carpal rotation), fixation and materials [20]. For the design 
of an intramedullary nail stabilising the bone while the 
fracture heals would be an important requirement [21]. 
2.3. Design Reviews 
  A design review is required, at each stage of the design 
process, to formally document comprehensive, systematic 
examination of a design to: 
•  evaluate design requirements 
•  assess capability of the design 
•  identify problems 
2.4. Design 
2.4.1. Concept Design 
  The concept, or conceptual, design stage is where 
solutions are generated to meet the design requirements. The 
aim is to generate as many ideas as possible. At this stage 
ideas should not be judged. Various methods exist to help 
with creativity in developing concept designs such as Brain 
storming [22-24] and TRIZ (Theory of Inventive Problem 
Solving) [22]. Concept design may involve: 
•  simple sketches of ideas; 
•  computer aided design models; 
•  analytical calculations; 
•  initial manufacturer consultation. 
  Once a range of concept designs have been developed it 
is worth assessing each of the concept designs for patentable 
technology to ensure that the final design has been fully 
protected. The protection of ideas and concepts can play an 
important role in the success of a product once launched to 
the market. It is therefore essential to consider this as early 
as possible in the design phase. 
  The range of concept designs can then be systematically 
rated by the design team to determine the most suitable 
concept to develop, in the detail design stage. A variety of 
methods for concept selection exist such as the Six Thinking 
Hats or the use of matrices where concepts are scored against 
a set of criteria that is required of the design [6,7,23,25].  
2.4.2. Detail Design 
  At the detail design stage the flesh is put onto the bones 
of the chosen conceptual idea [7]. A concept design is 
worked through until a detail design has been produced. This 
will include: 
•  generation of solid computer aided design models 
•  specification of materials 24    The Open Biomedical Engineering Journal, 2009, Volume 3  Aitchison et al. 
•  drafting of engineering drawings 
•  analysis of tolerance stacks within associated 
assemblies to ensure correct operation 
•  detailing with the inspection requirements to ensure 
that the part/assembly operates correctly 
•  liaison with manufacturers to ensure that the device is 
designed for manufacture (DFM), designed for 
assembly (DFA) or designed for manufacture and 
assembly (DFMA) 
2.5. Design Verification 
2.5.1. Introduction 
 Design verification involves confirmation by 
examination that a medical device meets the design 
requirements and is essentially asking the question “are we 
building the thing right?” [26,27]. It is essential that 
verification is considered early in the design process. Ideally, 
when a design requirement is decided, a method for 
verifying that requirement should also be developed [27]. 
Design verification methods can include: 
•  finite element analysis 
•  risk analysis 
•  rapid prototyping 
2.5.2. Finite Element Analysis 
  Finite element analysis is a widely used technique in 
medical device design and can be used to verify if a design 
will have sufficient strength to withstand the loading 
conditions in the human body [28]. Finite element analysis is 
a proven cost saving tool and can reduce design cycle time. 
In the development of a new method for closing a median 
sternotomy using cannulated screws and wire, finite element 
analysis was used to investigate the stresses acting between 
the screw and sternum [29]. In knee replacement implants, 
finite element analysis can be used to optimise the bearing 
surfaces [30]. Finite element analysis can also be used to 
investigate design changes to existing devices. For example, 
Mathias et al. [31] used finite element analysis to investigate 
the effect of introducing holes into the femoral component of 
a total hip replacement implant to engage with a stem 
introducer instrument and Leahy et al. [15] undertook a 
redesign of a flexible fixation system for the lumbar spine 
based on an existing design. 
2.5.3. Risk Analysis 
  A key part of the medical device design process is to 
undertake a risk analysis [32]. Any medical device should be 
designed and manufactured so that it does not compromise 
the safety of patients or healthcare workers. Manufacturers 
must eliminate or reduce risks as far as possible; any risks 
that exist must be weighed against the benefits to the patient. 
The way to show risks have been eliminated or reduced is to 
undertake a risk analysis. Many techniques, such as Failure 
Mode Effect Analysis and Fault Tree Analysis can be used in 
a risk analysis; guidance for these methods can be found in 
standards [33] and [34], respectively. Failure Mode Effects 
Analysis (FMEA) can have a number of variants which 
address different aspects of the product development cycle, 
all of which use a bottom-up approach to evaluate risks 
associated with aspects of the design. Examples of the 
variants are Design Failure Mode Effects Analysis 
(DFMEA), Process Failure Mode Effects Analysis 
(PFMEA), Failure Mode Criticality Analysis (FMECA) and 
User Failure Mode Effects Analysis (UFMEA). The aim of 
these methods is to consider all the possible risks associated 
with a medical device and identify ways that these risks can 
be eliminated or reduced. In FMEA the occurrence, severity, 
and detection of each failure are rated on a scale from 1 to 
10. A risk priority number is then calculated by multiplying 
the three ratings together. The design team must then decide 
if a possible failure mode is acceptable or if ways need to be 
found to reduce it. A partial risk analysis for a Swanson wrist 
implant is shown in Table 1 [32]. 
  It is also important not to isolate the medical device from 
the surgical instruments, packaging, sterilization and 
labeling; these have many risks associated with them that 
could adversely affect the performance of a medical device. 
An international standard for medical device risk analysis 
has been published [35]. Risk analysis helps to realise a 
design if it is undertaken at an early stage and should be 
undertaken at stages during the design process, including a 
final risk analysis. 
2.5.4. Rapid Prototyping 
  Rapid prototyping is a very effect technique for verifying 
the design of medical devices as it aids communication 
between engineers and surgeons [36]. Models of implants 
can be produced within hours by a variety of methods such 
as Selective Laser Sintering (SLS), Fused Deposition 
Modeling (FDM) or three-dimensional printing [37]. The 
surgeon can then inspect the models and size them against a 
skeleton. Rapid prototyping can also be used to produce 
models of human bones, which is particular useful if there is 
abnormal anatomy into which an implant will be used [38]. 
Multi-component systems can also benefit from the use of 
rapid prototyping as they allow designers to evaluate the 
interaction between components, such as a screw and a 
screw driver, thus minimising the opportunity for component 
incompatibility. 
2.6. Manufacture 
  Before the design is transferred to production it is 
essential to ensure that the chosen manufacturing processes 
are repeatable and reliable. The choice of manufacturing 
technique depends on many factors: 
•  number to be produced 
•  surface finish required 
•  post machining cleaning processes 
•  sterilization process (if necessary) 
  As well as the manufacture of the devices and the 
surgical instruments required to implant the device, 
packaging for the device and instruments, sterilization 
techniques, operation instructions and labeling printing 
requirements also need to be finalised. 
2.7. Design Validation 
  Validation of the device is performed under actual or 
simulated conditions for use. While verification is answering 
the question “are we building the thing right”, validation is Design Process for Medical Devices  The Open Biomedical Engineering Journal, 2009, Volume 3    25 
asking “have we built the right thing” [26,27]. Validation is 
to ensure that the medical device meets the user requirements 
and the intended use. Validation can include: 
•  mechanical testing of prototypes 
•  evidence that similar medical devices are clinically 
safe 
•  a clinical investigation 
•  sterilization validation 
  Mechanical testing allows the mechanical conditions in 
the human body to be simulated in the laboratory. 
Mechanical testing will give no indication of how the device 
will behave in the body from a biological point of view, but 
it will ensure that devices have sufficient strength and 
stiffness to perform as required. There are a large number of 
standards available to guide the pre-clinical mechanical 
testing of joint replacement implants. For a total hip joint 
replacement it would be necessary to: 
•  determine the endurance properties of the stem to BS 
7251-12 [39] by using a materials testing machine to 
apply a sinusoidally varying force (between 300 N 
and 2300 N) for up to 5 million cycles; 
•  to determine the wear of the bearing surfaces to BS 
ISO 14242-1 [40] by using a hip simulator to subject 
a hip replacement implant to loads of up to 3000 N 
and motions similar to those encountered in the body. 
The amount of wear is determined at 0.5 million and 
1 million cycles and then at least every 1 million 
cycles up to 5 million cycles using either the 
gravimetric or dimensional methods to determine the 
wear rate. 
  In some cases of mechanical testing it is beneficial to use 
human cadaveric material [41]. For example, cadavers have 
been used to investigate the attachment of a hook device to 
the spinous process of the lumbar spine in terms of strength 
and slippage [42,43]. In addition, cadavers can be used to 
trial surgical instruments [44]. 
 Once pre-clinical testing has been completed 
manufacturers of joint replacement implants are required to 
make a decision as to whether a clinical investigation is 
required. This is guided by the standard BS EN ISO 14155-1 
[45]. A critical review of the literature is required to 
ascertain similar implants and how they have performed in 
patients. Analogy may be used to justify not undertaking a 
clinical investigation. If the manufacturer does decide that a 
clinical investigation is required a clinical investigation plan 
must be produced in accordance with BS EN ISO 14155-2 
[46]. The investigation will need Ethics Committee approval 
and the manufacturer will be required to decide on the length 
of the investigation, the number of patients to be involved 
and the type of data to be collected. 
2.8. Design Transfer 
  Before a design is transferred to production it is 
necessary to ensure that all documents and training 
associated with the device are in place. Design transfer can 
include: 
•  generation of instructions for use 
•  finalization of the surgical technique 
•  plan the training of surgeons 
•  finalization of the labeling and packaging 
•  completed vendor requirements such as audits, first 
article inspection or surveys 
•  Total cost bill of materials 
•  completed inspection plans and process worksheets 
•  creation of the master device record 
2.9. Design Changes 
  After a medical device is on the market it is necessary for 
the manufacturer to have a post-market surveillance process 
in place to ensure the safety of patients and healthcare 
workers after the device is on the market. Feedback from 
Table 1.  Partial Results of a Risk Analysis for the Swanson Wrist Implant. The Occurrence (O), Severity (S) and Detection (D) are 
Rated on a Scale of 1 to 10 and Multiplied Together to Give a Risk Priority Number (RPN) 
Possible Failure Mode  Effect of Failure Cause  of  Failure  O  S  D  RPN  Action to Reduce or 
Eliminate Risk 
Breaks  Device does not function as 
intended 
Fatigue failure  10  6  5  300   
   Tears from sharp edges of 
bone 
10 6  5  300  Grommets have been 
designed for use with the 
Swanson wrist implant 
   Damaged during 
implantation using sharp 
instruments 
2 6 5  60  Use of correct 
instrumentation; trained 
hand surgeon; adequate and 
clear instructions for use 
   Incorrect implantation 
technique 
2 6 5  60  Trained hand surgeon; 
adequate instructions for 
use 
Wear particles of silicone  Silicone synovitis  Implant rubbing against bone  8 6 7  336   26    The Open Biomedical Engineering Journal, 2009, Volume 3  Aitchison et al. 
surgeons may lead to design changes being made to the 
device or the surgical instruments. The changes that arise 
from this feedback must be fully documented and the effects 
upon the device fully investigated. This latter process may 
involve repeating much of the verification and validation 
processes, depending upon the magnitude of the change. All 
design changes must be accompanied by an updated risk 
assessment to ensure that the full impact of the change has 
been understood. 
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